371 related articles for article (PubMed ID: 16888676)
1. [Correlations of insulin resistance and neoplasms].
Suba Z; Ujpál M
Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
3. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
4. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
Rader DJ
Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
[TBL] [Abstract][Full Text] [Related]
5. Vegan proteins may reduce risk of cancer, obesity, and cardiovascular disease by promoting increased glucagon activity.
McCarty MF
Med Hypotheses; 1999 Dec; 53(6):459-85. PubMed ID: 10687887
[TBL] [Abstract][Full Text] [Related]
6. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
7. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development.
Becker S; Dossus L; Kaaks R
Arch Physiol Biochem; 2009 May; 115(2):86-96. PubMed ID: 19485704
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
[TBL] [Abstract][Full Text] [Related]
9. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
[TBL] [Abstract][Full Text] [Related]
10. The clinical implications of insulin resistance.
Peters AL
Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus, hyperglycaemia and cancer.
Simon D; Balkau B
Diabetes Metab; 2010 Jun; 36(3):182-91. PubMed ID: 20554237
[TBL] [Abstract][Full Text] [Related]
12. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.
Giovannucci E; Michaud D
Gastroenterology; 2007 May; 132(6):2208-25. PubMed ID: 17498513
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance in obesity as the underlying cause for the metabolic syndrome.
Gallagher EJ; Leroith D; Karnieli E
Mt Sinai J Med; 2010; 77(5):511-23. PubMed ID: 20960553
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic criteria of insulin resistance and multiple risk factor syndrome].
Hashimoto N; Saito Y
Nihon Rinsho; 2000 Feb; 58(2):405-10. PubMed ID: 10707566
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
16. Management issues in the metabolic syndrome.
Deedwania PC; Gupta R
J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277
[TBL] [Abstract][Full Text] [Related]
17. Insulin-resistance and benign prostatic hyperplasia: the connection.
Vikram A; Jena G; Ramarao P
Eur J Pharmacol; 2010 Sep; 641(2-3):75-81. PubMed ID: 20553919
[TBL] [Abstract][Full Text] [Related]
18. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk.
Bergman RN; Kim SP; Hsu IR; Catalano KJ; Chiu JD; Kabir M; Richey JM; Ader M
Am J Med; 2007 Feb; 120(2 Suppl 1):S3-8; discussion S29-32. PubMed ID: 17296343
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes.
Groop PH; Forsblom C; Thomas MC
Nat Clin Pract Endocrinol Metab; 2005 Dec; 1(2):100-10. PubMed ID: 16929378
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic syndrome with vascular risk and arterial hypertension].
Wassermann AO; Grosso CP
Medicina (B Aires); 1996; 56(2):183-94. PubMed ID: 8935572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
